ADIENNE is dedicated to

developing innovative technologies and treatments for severe diseases

with a main purpose to understand and dissect pathogenetic mechanisms of specific medical conditions.
ManufacturingManufacturing

ADIENNE is dedicated to

the treatment of rare and severe diseases

ADIENNE is focused on the treatment of various hematological and immunological diseases

Biopharmaceutical group

Biopharmaceutical group

ADIENNE is a global leader in the biopharmaceutical field of

lyophilization of cytotoxic product in ready to use system

lyophilization of cytotoxic product in ready to use system

ADIENNE is an integrated biopharmaceutical group with its headquarter based in Lugano, Switzerland, and its Pharma & Biotech manufacturing facilities based in Caponago, Italy.

With a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

ADIENNE’s R&D team focus on rare diseases with a main purpose to understand and dissect pathogenetic mechanisms of specific medical conditions